Related Experiment Video
Updated: Jun 3, 2026
15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
Animal and human dose-response models for Brucella species
Sondra S Teske1, Yin Huang, Sushil B Tamrakar
1Department of Civil, Architectural, and Environmental Engineering, Drexel University, Philadelphia, PA, USA. ssteske@gmail.com
Summary
Human Brucellosis, a common zoonotic disease, lacks a human vaccine. Understanding Brucella dose-response is crucial for risk assessment and bioterrorism preparedness, especially for aerosolized forms.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Microbiology
Background:
- Human Brucellosis is a prevalent zoonotic disease globally, transmitted via livestock and contaminated products.
- Lack of a human vaccine and its classification as a Bioterrorism/Select Agent necessitate understanding Brucella dose-response.
- Aerosolized transmission poses enhanced infectivity risks.
Purpose of the Study:
- To develop dose-response models for prevalent Brucella species (Br. suis, Br. melitensis, Br. abortus).
- To assess the infectious dose of Brucella via different exposure routes in animal models.
- To inform quantitative risk assessment for Brucellosis.
Main Methods:
- Extensive literature search and quality appraisal of dose-response data.
- Application of maximum likelihood estimation using the R programming language.
- Fitting exponential and beta-Poisson models to Brucella dose-response data.
Main Results:
- Dose-response models were generated for Br. suis, Br. melitensis, and Br. abortus.
- Median infectious dose for aerosolized Br. suis in guinea pigs was determined.
- Comparative analysis revealed lower infectious doses for Br. suis compared to Br. melitensis in guinea pigs, and higher N(50) for subcutaneous Br. melitensis in mice.
Conclusions:
- Established dose-response models provide critical data for Brucellosis risk assessment.
- Findings highlight variations in infectious dose based on Brucella species and exposure route.
- Further research into Brucella infectivity and host response is warranted.
Related Concept Videos
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...